C‐reactive protein is expressed and secreted by peripheral blood mononuclear cells

Summary C‐reactive protein (CRP) protects against bacterial pathogens and is a predictor of cardiovascular events. CRP is produced by vascular and organ‐specific cells but the generation of CRP from peripheral blood mononuclear cells (PBMC) is poorly established. In a randomized, double‐blind, placebo‐controlled, two‐way cross‐over trial six healthy volunteers received a bolus infusion of 20 IU/kg Escherichia coli endotoxin [lipopolysaccharide (LPS)] or placebo. Intracellular CRP protein and CRP secretion of peripheral blood mononuclear cells (PBMC) was measured at baseline and 6 h after LPS by flow cytometry and enzyme‐linked immubosorbent assay (ELISA), respectively. CRP mRNA expression was determined by real‐time polymerase chain reaction (PCR). Regulation of the expression pathway was assessed using specific inhibitors in vitro . Small amounts of CRP protein and mRNA were detectable in PBMC, which were up‐regulated between two‐ and eightfold by endotoxaemia in vivo . Augmented expression and release of CRP by LPS was consistent in PBMC cell culture experiments. LPS, interleukin (IL)‐1, IL‐6 and tumour necrosis factor (TNF)‐α increased and IL‐10 reduced CRP expression in PBMC. Toll‐like receptor (TLR)‐4, nuclear factor (NF)‐κB and protein kinase C (PKC) activation were identified as intracellular signal transduction pathways of LPS‐induced CRP expression. Constitutive CRP expression and release in PBMC is enhanced by inflammatory stimuli in vivo and in vitro . LPS might induce CRP generation via activation of TLR‐4, NF‐κB and PKC.